AptaBio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	210,481	171,234	201,805	237,483
Market Cap Growth	26.74%	-15.15%	-15.02%	-
Enterprise Value	193,525	146,945	152,862	-
Last Close Price	7830.00	6370.00	9050.00	10650.00
Forward PE	-	78.10	78.10	78.10
PS Ratio	67.76	50.95	623.11	4911.46
PB Ratio	4.07	3.16	3.29	4.54
P/TBV Ratio	4.07	3.16	3.32	4.54
EV/Sales Ratio	62.30	43.72	471.99	-
Debt / Equity Ratio	0.15	0.14	0.23	0.01
Asset Turnover	0.04	0.04	0.00	-
Quick Ratio	1.59	1.67	65.10	16.58
Current Ratio	1.79	1.79	70.27	19.63
Return on Equity (ROE)	-51.24%	-50.84%	-21.21%	-
Return on Assets (ROA)	-15.63%	-15.24%	-14.22%	-
Return on Capital (ROIC)	-19.16%	-18.90%	-16.50%	-
Earnings Yield	-13.30%	-17.16%	-5.98%	-4.45%
FCF Yield	-7.85%	-7.24%	-7.65%	-3.32%
Buyback Yield / Dilution	-6.87%	-5.58%	-0.05%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.